arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Cardiff Oncology, Inc.

CRDF

$1.00 ▲ +0.03 (+2.67%) at close

27 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Cardiff Oncology, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $66.8M

Dividend Yield —

Revenue Growth -13.2% ↘

Op. Margin —

ROIC -107.9% ↘

FCF / Share $-0.57 ↗

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$593.00K

↓ -13.2% —

Net Income Profit after all expenses

$-45.85M

↓ -0.9% —

FCF / Share Free cash flow per share

$-0.57

↑ +28.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jan 31, 2007 10-K ↗	FY 2005 Jan 31, 2006 10-K ↗	FY 2004 Jan 31, 2005 10-K ↗	FY 2003 Jan 31, 2004 10-K ↗	FY 2002 Jan 31, 2003 10-K ↗	FY 2001 Jan 31, 2002 10-K ↗	FY 2000 Jan 31, 2001 10-K ↗	FY 1999 Jan 31, 2000 10-K ↗
Revenue Growth YoY (%)	-13.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-265%)	40.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+399%)	26.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+230%)	7.5% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-6%)	-1.9% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-124%)	49.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+520%)	-35.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-542%)	-25.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-414%)	32.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+308%)	21.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+173%)	11.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+46%)	8.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	-89.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1218%)	854.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10576%)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	27.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-4.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-21.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	32.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	-3881.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-23.8% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-38.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-8.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-0.9% Weak ↑ Weak Improving Year-over-year change in net income	-9.6% Weak ↑ Weak Improving Year-over-year change in net income	-7.1% Weak ↑ Weak Improving Year-over-year change in net income	-36.8% Weak ↓ Weak Declining Year-over-year change in net income	-46.5% Weak ↓ Weak Declining Year-over-year change in net income	-17.6% Weak ↓ Weak Declining Year-over-year change in net income	0.3% Caution ↓ Caution Declining Year-over-year change in net income	33.9% Excellent ↑ Excellent Improving Year-over-year change in net income	36.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-42.7% Weak ↓ Weak Declining Year-over-year change in net income	-91.8% Weak ↑ Weak Improving Year-over-year change in net income	-21.3% Weak ↑ Weak Improving Year-over-year change in net income	78.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-2294.1% Weak ↓ Weak Declining Year-over-year change in net income	58.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-119.4% Weak ↓ Weak Declining Year-over-year change in net income	51.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-10.3% Weak ↓ Weak Declining Year-over-year change in net income	34.4% Excellent ↑ Excellent Improving Year-over-year change in net income	9.1% Fair ↑ Fair Improving Year-over-year change in net income	-46.0% Weak ↑ Weak Improving Year-over-year change in net income	-1302.3% Weak ↓ Weak Declining Year-over-year change in net income	20.5% Good ↑ Good Improving Year-over-year change in net income	8.1% Fair Fair Year-over-year change in net income	-95.9% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	28.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-12.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	11.8% Fair ↓ Fair Declining Year-over-year change in free cash flow	-34.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	24.8% Good ↓ Good Declining Year-over-year change in free cash flow	64.5% Excellent Excellent Year-over-year change in free cash flow	60.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	15.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	23.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	10.1% Good ↑ Good Improving Compound annual revenue growth over 3 years	16.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-1.7% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-10.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-13.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	6.5% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	21.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	13.7% Good ↑ Good Improving Compound annual revenue growth over 3 years	-49.7% Weak Weak Compound annual revenue growth over 3 years	2.8% Caution Caution Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	10.1% Good ↑ Good Improving Compound annual revenue growth over 5 years	22.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	5.2% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-5.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-1.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	3.2% Caution ↑ Caution Improving Compound annual revenue growth over 5 years	-2.7% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	7.9% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-27.1% Weak Weak Compound annual revenue growth over 5 years	8.1% Good Good Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jan 31, 2007 10-K ↗	FY 2005 Jan 31, 2006 10-K ↗	FY 2004 Jan 31, 2005 10-K ↗	FY 2003 Jan 31, 2004 10-K ↗	FY 2002 Jan 31, 2003 10-K ↗	FY 2001 Jan 31, 2002 10-K ↗	FY 2000 Jan 31, 2001 10-K ↗	FY 1999 Jan 31, 2000 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jan 31, 2007 10-K ↗	FY 2005 Jan 31, 2006 10-K ↗	FY 2004 Jan 31, 2005 10-K ↗	FY 2003 Jan 31, 2004 10-K ↗	FY 2002 Jan 31, 2003 10-K ↗	FY 2001 Jan 31, 2002 10-K ↗	FY 2000 Jan 31, 2001 10-K ↗	FY 1999 Jan 31, 2000 10-K ↗
Return on Invested Capital (%)	-107.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-58.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-180.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-133.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-310.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-160.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-141.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1587.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	55.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-79.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-55.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-127.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-120.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-208.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-91.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-373.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-286.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-101.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-773%)	-54.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-465%)	-59.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-496%)	-36.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-343%)	-20.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-15.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-224.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1597%)	-163.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1188%)	—	-198.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1422%)	-56.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-476%)	-171.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1244%)	-57.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-486%)	—	52.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+253%)	109.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+627%)	65.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+337%)	127.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+751%)	284.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1797%)	—	-225.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1602%)	-168.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1222%)	24.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+62%)	40.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+169%)	72.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+386%)	111.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+642%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jan 31, 2007 10-K ↗	FY 2005 Jan 31, 2006 10-K ↗	FY 2004 Jan 31, 2005 10-K ↗	FY 2003 Jan 31, 2004 10-K ↗	FY 2002 Jan 31, 2003 10-K ↗	FY 2001 Jan 31, 2002 10-K ↗	FY 2000 Jan 31, 2001 10-K ↗	FY 1999 Jan 31, 2000 10-K ↗
Interest Coverage (x)	—	—	—	—	—	-9543.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-671.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.76x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-23.98x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.72x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-628.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-32.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	-52.56x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-17.47M	$-51.47M	$-21.66M	$-16.35M	$-11.94M	$-130.98M	$-10.20M	$-11.45M	$-8.23M	$-13.92M	$-67.49M	$-27.29M	$-25.84M	$-10.82M	$-700.37K	$-58.70K	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jan 31, 2007 10-K ↗	FY 2005 Jan 31, 2006 10-K ↗	FY 2004 Jan 31, 2005 10-K ↗	FY 2003 Jan 31, 2004 10-K ↗	FY 2002 Jan 31, 2003 10-K ↗	FY 2001 Jan 31, 2002 10-K ↗	FY 2000 Jan 31, 2001 10-K ↗	FY 1999 Jan 31, 2000 10-K ↗
Revenue per Share (USD)	$0.01	$0.01	$0.01	$0.01	$0.01	$0.02	$0.04	$0.16	$1.05	$0.01	$0.01	$0.01	$0.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.69	$-0.95	$-0.93	$-0.89	$-0.73	$-1.08	—	—	$-51.76	$-1.30	$-1.05	$-0.76	$-0.70	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.57	$-0.79	$-0.70	$-0.80	$-0.60	$-0.79	$-2.23	$-5.67	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.66	$1.25	$1.56	$2.38	$3.35	$3.48	$0.85	$2.63	$8.87	$0.64	$1.64	$0.44	$1.08	$0.14	$-0.39	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.66	$1.25	$1.56	$2.38	$3.35	$3.48	$0.85	$2.63	$8.87	$0.64	$1.64	$0.44	$1.08	$0.14	$-0.39	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	66.84M	47.65M	44.68M	43.60M	39.03M	20.88M	5.97M	2.33M	481,672	30.17M	26.20M	18.90M	16.98M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jan 31, 2007 10-K ↗	FY 2005 Jan 31, 2006 10-K ↗	FY 2004 Jan 31, 2005 10-K ↗	FY 2003 Jan 31, 2004 10-K ↗	FY 2002 Jan 31, 2003 10-K ↗	FY 2001 Jan 31, 2002 10-K ↗	FY 2000 Jan 31, 2001 10-K ↗	FY 1999 Jan 31, 2000 10-K ↗
Working Capital (USD)	$43.73M	$81.63M	$66.97M	$103.48M	$139.57M	$127.24M	$6.57M	$9.84M	$5.52M	$31.15M	$60.18M	$23.23M	$24.06M	$10.32M	$-587.71K	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$45.39M	$82.95M	$69.74M	$106.34M	$140.42M	$128.16M	$7.31M	$10.08M	$6.51M	$19.77M	$48.70M	$8.35M	$20.39M	$2.17M	$-4.23M	$-5.00M	$-3.79M	$-4.05M	$-1.65M	$1.13M	$3.48M	$3.19M	$-1.58M	$-1.20M	$-719.39K	$-240.36K	$27.24K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Jan 31, 2007 10-K ↗	FY 2005 Jan 31, 2006 10-K ↗	FY 2004 Jan 31, 2005 10-K ↗	FY 2003 Jan 31, 2004 10-K ↗	FY 2002 Jan 31, 2003 10-K ↗	FY 2001 Jan 31, 2002 10-K ↗	FY 2000 Jan 31, 2001 10-K ↗	FY 1999 Jan 31, 2000 10-K ↗
Sales/Revenue/Turnover (USD)	$593.00K	$683.00K	$488.00K	$386.00K	$359.00K	$366.00K	$244.63K	$378.32K	$505.40K	$381.07K	$312.81K	$280.18K	$259.25K	$2.46M	$257.70K	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$364.00K	$404.00K	$398.00K	$236.00K	$451.00K	$466.00K	$494.23K	$859.49K	$1.25M	$1.07M	$378.71K	$234.81K	$130.52K	$259.64K	$10.29K	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-45.85M	$-45.43M	$-41.44M	$-38.70M	$-28.29M	$-19.31M	$-16.41M	$-16.46M	$-24.91M	$-39.20M	$-27.47M	$-14.33M	$-11.81M	$-53.61M	$-2.24M	$-5.45M	$-2.48M	$-5.17M	$-4.68M	$-7.13M	$-7.84M	$-5.37M	$-383.02K	$-481.61K	$-524.22K	$-267.60K	—
Operating Cash Flow (USD)	$-37.92M	$-37.69M	$-30.89M	$-33.82M	$-23.04M	$-16.32M	$-13.27M	$-13.20M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 27 years · 107 quarters

Cardiff Oncology, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CRDF with peers